During the past decade, Children's Cancer and Leukaemia Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Children's Cancer and Leukaemia Group" are "Childhood Langerhans Cell Histiocytosis" (1 trials) and "Liver Cancer" (1 trials). Many other conditions were trialed in "Children's Cancer and Leukaemia Group" in a lesser frequency.

Most popular intervention types in "Children's Cancer and Leukaemia Group" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (1 trials), "carboplatin" (1 trials), "cisplatin" (1 trials), "conventional surgery" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Cancer and Leukaemia Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Children's Cancer and Leukaemia Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Children's Cancer and Leukaemia Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Children's Cancer and Leukaemia Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".